ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,279,000 | +40.8% | 76,545 | +20.8% | 0.01% | +30.0% |
| Q3 2016 | $8,011,000 | +12.7% | 63,386 | +0.6% | 0.01% | +11.1% |
| Q2 2016 | $7,108,000 | +19.5% | 63,038 | +10.4% | 0.01% | +12.5% |
| Q1 2016 | $5,947,000 | -5.3% | 57,123 | +2.6% | 0.01% | 0.0% |
| Q4 2015 | $6,277,000 | +3.3% | 55,656 | +0.3% | 0.01% | 0.0% |
| Q3 2015 | $6,074,000 | +13.8% | 55,466 | -0.6% | 0.01% | +14.3% |
| Q2 2015 | $5,337,000 | +14.3% | 55,793 | +11.2% | 0.01% | +16.7% |
| Q1 2015 | $4,671,000 | +15.9% | 50,154 | +1.9% | 0.01% | +20.0% |
| Q4 2014 | $4,030,000 | +26.2% | 49,204 | -1.1% | 0.01% | +25.0% |
| Q3 2014 | $3,193,000 | +6.8% | 49,752 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $2,990,000 | +13.6% | 49,170 | +11.9% | 0.00% | 0.0% |
| Q1 2014 | $2,632,000 | -5.3% | 43,959 | +0.8% | 0.00% | 0.0% |
| Q4 2013 | $2,778,000 | -7.4% | 43,606 | -1.3% | 0.00% | -20.0% |
| Q3 2013 | $3,001,000 | -0.5% | 44,185 | +5.6% | 0.01% | 0.0% |
| Q2 2013 | $3,015,000 | – | 41,843 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |